Dr. Reddy’s receives EIR from USFDA for Srikakulam plant

26 Feb 2018 Evaluate

Dr. Reddy’s Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its formulations facility at Srikakulam in the state of Andhra Pradesh.

USFDA has maintained Official Action Indicated (OAI) status at its API manufacturing plant at Srikakulam.

Dr. Reddy’s Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.


Dr. Reddys Lab Share Price

1175.55 -10.90 (-0.92%)
16-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1669.20
Dr. Reddys Lab 1175.55
Cipla 1397.95
Zydus Lifesciences 867.80
Lupin 2176.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×